LINC02836

Across TCGA pan-cancer cohorts, LINC02836 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of LINC02836’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02836 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02836 is over-expressed in tumor.

KIRC, LUSC, and PRAD are the cancer types where LINC02836 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02836 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	+0.076	<.001	9	view →
LUSC	All	All	+0.139	<.001	3	view →
PRAD	All	All	+0.558	.022	2	view →
LUAD	All	All	+0.119	.005	2	view →
COAD	All	II,III,IV	+0.041	.043	2	view →
HNSC	Male	IV	+0.105	.014	1	view →
KIRP	All	III,IV	+0.031	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

LINC02836–KIRC

Open the KIRC breakdown →